◂ Announcements

Aug 9, 2023ACQUISITIONUnited States

ExoCoBio acquires majority ownership of BENEV

ExoCoBio, a leader in exosomes technology, has completed the acquisition of majority ownership of BENEV, a US FDA-registered manufacturer of pharmaceutical, cosmeceutical, and medical devices.

Status

Completed

Productsexosomes technologySylfirm XMiracu PDO threadsBENEV Exosomes

CompaniesExoCoBio acquirer BENEV target

Sectors#Medical Devices

“We are very pleased with this important acquisition, which will contribute to the fast growth and business expansion of ExoCoBio.”benev.com

1 source
benev.comMeet ExoCoBio, Our Strategic Partner in Advancing Exosomes TechnologyBianca PerezAug 9, 2023

Summarized from public sources; check the original articles before acting on it.

Similar announcements

Nov 6, 2026ACQUISITIONMinnesota, United States
Confluent Medical Technologies acquires Northern Nitinol
Confluent Medical Technologies acquirer Northern Nitinol target globenewswire.com
Nov 6, 2026ACQUISITIONUnited States$9.90B
Danaher to acquire Masimo for $9.9 billion
Danaher acquirer Masimo target mdtvnow.com endata.com
Nov 5, 2026ACQUISITIONUnited States
Curewell Capital to acquire majority stake in ECA Medical
Curewell Capital acquirer ECA Medical target businesswire.com
Nov 5, 2026ACQUISITIONUnited States$538.0M
ZOLL Medical to acquire Itamar Medical for $538M
Asahi Kasei investor ZOLL Medical Corporation acquirer forpressrelease.com
Nov 4, 2026ACQUISITIONPlano, Texas, United States$2.25M
OSTEONIC acquires controlling stake in FoxEyes for 3 billion won
OSTEONIC FoxEyes target en.edaily.co.kr
Nov 3, 2026ACQUISITIONDeerfield, Illinois, United States
Vantive to divest majority of hemodialysis assets to Rockwell Medical
Vantive Rockwell Medical acquirer prnewswire.com

Loading…